MCE 的所有产品仅用作科学研究或药证申报，我们不为任何个人用途提供产品和服务。

Apalutamide

CAS No. : 956104-40-8

MCE 国际站：Apalutamide

产品活性：Apalutamide (ARN-509) 是有效，竞争性的雄激素受体 (AR) 拮抗剂，IC₅₀ 为 16 nM。

研究领域：Vitamin D Related/Nuclear Receptor

作用靶点：Androgen Receptor

In Vitro: Apalutamide (ARN-509) also exhibits low micromolar affinity (IC₅₀ 3 μM) for the GABA_A receptor in radioligand binding-assays and thus may potentially antagonize GABA_A at therapeutic dose levels. Apalutamide is a potent androgen receptor (AR) antagonist that targets the AR ligand-binding domain and prevents AR nuclear translocation, DNA binding, and transcription of AR gene targets.

In Vivo: Apalutamide (ARN-509) exhibits low systemic clearance, high oral bioavailability and long plasma half-life in both mouse and dog, supporting once-daily oral dosing. Consistent with its long terminal-half-life, Apalutamide steady-state plasma-levels increases in repeat-dose studies, resulting in high C_24hr levels and low peak:trough ratios (ratio:2.5). Castrate male mice bearing LNCaP/AR xenograft tumors are treated with either Apalutamide at doses of 1, 10 or 30 mg/kg/day. Thirteen of 20 Apalutamide (30 mg/kg/day)-treated animals exhibit >50% reduction in tumor-volume at day 28 versus 3 of 19 MDV3100 (30 mg/kg/day)-treated mice.

相关产品：Covalent Screening Library Plus  |  Drug Repurposing Compound Library Plus  |  FDA-Approved Drug Library Plus  |  FDA-Approved Drug Library Mini  |  Bioactive Compound Library Plus  |  FDA-Approved Drug Library  |  Anti-Cancer Compound Library  |  Drug Repurposing Compound Library  |  Covalent Screening Library  |  Orally Active Compound Library  |  FDA Approved & Pharmacopeial Drug Library  |  Drug-Induced Liver Injury (DILI) Compound Library  |  Targeted Therapy Drug Library   |  Transcription Factor-Targeted Library  |  EMA-Approved Drug Library  |  FDA-Approved Anticancer Drug Library  |  Human Metabolite Library  |  Anti-Prostate Cancer Compound Library  |  Nuclear Receptor Compound Library  |  Heterocyclic Compound Library  |  Cysteine Targeted Covalent Library  |  Medroxyprogesterone acetate-d₃  |  Androgen receptor antagonist 4  |  VPC-13789  |  Acetyl-ACTH (7-24) (human, bovine, rat)  |  CSRM617 hydrochloride  |  Ar-V7-IN-1  |  Acetyl-ACTH (3-24) (human, bovine, rat)  |  Cyproterone acetate-d₃  |  TD-802  |  GTx-007  |  RD162  |  MK-4541  |  S-23  |  MI-136  |  MK-3984  |  Boc-Glycine-2-¹³C  |  SK33  |  Brassicasterol  |  Medroxyprogesterone acetate  |  Apalutamide-d₃  |  Cyprodinil  |  Linuron  |  ARV-766  |  DHEA  |  CLP-3094  |  AR antagonist 2  |  Prochloraz  |  D4-abiraterone  |  Spironolactone-d₃-1

热门产品线：重组蛋白  |  化合物库  |  天然产物  |  荧光染料  |  PROTAC  |  同位素标记物  |  寡核苷酸  |  抗体  |  点击化学

Trending products：Recombinant Proteins  |  Bioactive Screening Libraries  |  Natural Products  |  Fluorescent Dye  |  PROTAC  |  Isotope-Labeled Compounds  |  Oligonucleotides  |  Antibodies  |  Click Chemistry

品牌介绍:
•   MCE (MedChemExpress) 拥有200 多种全球独家化合物库，我们致力于为全球科研客户提供前沿最全的高品质小分子活性化合物；
•   50,000 多种高选择性抑制剂、激动剂涉及各热门信号通路及疾病领；
•   产品种类涵盖各种重组蛋白，多肽，常用试剂盒 ，更有 PROTAC、ADC 等特色产品，广泛应用于新药研发、生命科学等科研项目；
•   提供虚拟筛选，离子通道筛选，代谢组学分析检测分析，药物筛选等专业技术服务；
•   设有专业的实验中心和严格的质控、验证体系；
•   提供 LC/MS、NMR、HPLC、手性分析、元素分析等各项质检报告，确保产品的高纯度、高品质；
•   产品的生物活性多经各国客户实验验证；
•   Nature, Cell, Science 等多种顶级期刊及制药专利收录了MCE客户的科研成果；
•   专业团队跟踪最新的制药及生命科学研究进展，为您提供全球最新的活性化合物；
•   与世界各大制药公司及知名科研机构建立了长期的合作。